{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T07:05:47Z","timestamp":1789110347139,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41375-026-02988-1","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:46:10Z","timestamp":1780919170000},"page":"1551-1555","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prolonged BCR::ABL1 induction in the SCL-tTA mouse recapitulates gene expression signatures and therapeutic vulnerabilities of primary imatinib-resistant chronic myeloid leukaemia"],"prefix":"10.1038","volume":"40","author":[{"given":"Pavithra","family":"Shyamsunder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0443-2746","authenticated-orcid":false,"given":"Kian Leong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu En","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Chuah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengge","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hari Priyaa","family":"Thever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4328-8072","authenticated-orcid":false,"given":"Giselle Sek Suan","family":"Nah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatin Nasha Bte","family":"Sulaimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5028-6567","authenticated-orcid":false,"given":"Vaidehi","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9460-3483","authenticated-orcid":false,"given":"S. Tiong","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"2988_CR1","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3324\/haematol.2021.279317","volume":"107","author":"V Krishnan","year":"2022","unstructured":"Krishnan V, Kim DDH, Hughes TP, Branford S, Ong ST. Integrating genetic and epigenetic factors in chronic myeloid leukemia risk assessment: toward gene expression-based biomarkers. Haematologica. 2022;107:358\u201370.","journal-title":"Haematologica"},{"key":"2988_CR2","first-page":"2738","volume":"141","author":"V Krishnan","year":"2023","unstructured":"Krishnan V, Schmidt F, Nawaz Z, Venkatesh PN, Lee KL, Ren X, et al. A single-cell atlas identifies pretreatment features of primary imatinib resistance in chronic myeloid leukemia. Blood. 2023;141:2738\u201355.","journal-title":"Blood"},{"key":"2988_CR3","doi-asserted-by":"crossref","unstructured":"Warfvinge R, Geironson Ulfsson L, Dhapola P, Safi F, Sommarin M, Soneji S, et al. Single-cell multiomics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy response. Elife. 2024;12:RP92074.","DOI":"10.7554\/eLife.92074"},{"key":"2988_CR4","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1182\/blood.2020004834","volume":"135","author":"TK Ko","year":"2020","unstructured":"Ko TK, Javed A, Lee KL, Pathiraja TN, Liu X, Malik S, et al. An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia. Blood. 2020;135:2337\u201353.","journal-title":"Blood"},{"key":"2988_CR5","first-page":"5716","volume":"63","author":"C Ly","year":"2003","unstructured":"Ly C, Arechiga AF, Melo JV, Walsh CM, Ong ST. Bcr-Abl kinase modulates the translation regulators ribosomal protein S6 and 4E-BP1 in chronic myelogenous leukemia cells via the mammalian target of rapamycin. Cancer Res. 2003;63:5716\u201322.","journal-title":"Cancer Res"},{"key":"2988_CR6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1365-2141.2006.06161.x","volume":"134","author":"P Coppo","year":"2006","unstructured":"Coppo P, Flamant S, De Mas V, Jarrier P, Guillier M, Bonnet ML, et al. BCR-ABL activates STAT3 via JAK and MEK pathways in human cells. Br J Haematol. 2006;134:171\u20139.","journal-title":"Br J Haematol"},{"key":"2988_CR7","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1158\/1541-7786.MCR-10-0356","volume":"9","author":"M Albajar","year":"2011","unstructured":"Albajar M, G\u00f3mez-Casares MT, Llorca J, Mauleon I, Vaque JP, Acosta JC, et al. MYC in chronic myeloid leukemia: induction of aberrant DNA synthesis and association with poor response to imatinib. Mol Cancer Res. 2011;9:564\u201376.","journal-title":"Mol Cancer Res"},{"key":"2988_CR8","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nature22314","volume":"545","author":"A Hattori","year":"2017","unstructured":"Hattori A, Tsunoda M, Konuma T, Kobayashi M, Nagy T, Glushka J, et al. Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia. Nature. 2017;545:500\u20134.","journal-title":"Nature"},{"key":"2988_CR9","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.stem.2022.06.012","volume":"29","author":"R Bogeska","year":"2022","unstructured":"Bogeska R, Mikecin AM, Kaschutnig P, Fawaz M, Buchler-Schaff M, Le D, et al. Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging. Cell Stem Cell. 2022;29:1273\u201384.e8.","journal-title":"Cell Stem Cell"},{"key":"2988_CR10","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1182\/blood-2009-04-215376","volume":"115","author":"M Schemionek","year":"2010","unstructured":"Schemionek M, Elling C, Steidl U, Baumer N, Hamilton A, Spieker T, et al. BCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cells. Blood. 2010;115:3185\u201395.","journal-title":"Blood"},{"key":"2988_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41588-018-0270-1","volume":"51","author":"SA Assi","year":"2019","unstructured":"Assi SA, Imperato MR, Coleman DJL, Pickin A, Potluri S, Ptasinska A, et al. Subtype-specific regulatory network rewiring in acute myeloid leukemia. Nat Genet. 2019;51:151\u201362.","journal-title":"Nat Genet"},{"key":"2988_CR12","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1038\/s41375-020-0977-8","volume":"34","author":"O Parting","year":"2020","unstructured":"Parting O, Langer S, Kuepper MK, Wessling C, Li S, Braunschweig T, et al. Therapeutic inhibition of FcgammaRIIb signaling targets leukemic stem cells in chronic myeloid leukemia. Leukemia. 2020;34:2635\u201347.","journal-title":"Leukemia"},{"key":"2988_CR13","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1182\/blood-2013-07-517847","volume":"123","author":"CI Kobayashi","year":"2014","unstructured":"Kobayashi CI, Takubo K, Kobayashi H, Nakamura-Ishizu A, Honda H, Kataoka K, et al. The IL-2\/CD25 axis maintains distinct subsets of chronic myeloid leukemia-initiating cells. Blood. 2014;123:2540\u20139.","journal-title":"Blood"},{"key":"2988_CR14","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/ajh.26650","volume":"97","author":"B Peter","year":"2022","unstructured":"Peter B, Eisenwort G, Sadovnik I, Bauer K, Willmann M, Rulicke T, et al. BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph(+) chronic myeloid leukemia. Am J Hematol. 2022;97:1215\u201325.","journal-title":"Am J Hematol"},{"key":"2988_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ccell.2017.11.009","volume":"33","author":"M Kleppe","year":"2018","unstructured":"Kleppe M, Koche R, Zou L, van Galen P, Hill CE, Dong L, et al. Dual targeting of oncogenic activation and inflammatory signaling increases therapeutic efficacy in myeloproliferative neoplasms. Cancer Cell. 2018;33:29\u201343.e7.","journal-title":"Cancer Cell"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-02988-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-02988-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-02988-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T06:06:00Z","timestamp":1789106760000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-02988-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2988"],"URL":"https:\/\/doi.org\/10.1038\/s41375-026-02988-1","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"4 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}